FI112249B - Hepatitis G virus ja sen molekyylikloonaus - Google Patents

Info

Publication number

FI112249B

FI112249B FI964605A FI964605A FI112249B FI 112249 B FI112249 B FI 112249B FI 964605 A FI964605 A FI 964605A FI 964605 A FI964605 A FI 964605A FI 112249 B FI112249 B FI 112249B

Authority

FI

Finland

Prior art keywords

hgv

sequence

polypeptide

seq

hepatitis

Prior art date

1994-05-20

Links

• Espacenet
• Global Dossier
• Discuss

• 241000531123 GB virus C Species 0.000 title abstract description 570
• 238000010369 molecular cloning Methods 0.000 title description 5
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 237
• 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 211
• 108091007433 antigens Proteins 0.000 claims abstract description 196
• 102000036639 antigens Human genes 0.000 claims abstract description 196
• 239000000427 antigen Substances 0.000 claims abstract description 191
• 229920001184 polypeptide Polymers 0.000 claims abstract description 184
• 238000000034 method Methods 0.000 claims abstract description 167
• 239000012634 fragment Substances 0.000 claims abstract description 93
• 208000006454 hepatitis Diseases 0.000 claims abstract description 87
• 102000040430 polynucleotide Human genes 0.000 claims abstract description 86
• 108091033319 polynucleotide Proteins 0.000 claims abstract description 86
• 239000002157 polynucleotide Substances 0.000 claims abstract description 86
• 231100000283 hepatitis Toxicity 0.000 claims abstract description 76
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 72
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 67
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 67
• 108700026244 Open Reading Frames Proteins 0.000 claims abstract description 47
• 238000001514 detection method Methods 0.000 claims abstract description 46
• 238000012360 testing method Methods 0.000 claims abstract description 34
• 229960005486 vaccine Drugs 0.000 claims abstract description 34
• 108090000623 proteins and genes Proteins 0.000 claims description 183
• 239000000523 sample Substances 0.000 claims description 172
• 210000002966 serum Anatomy 0.000 claims description 160
• 102000004169 proteins and genes Human genes 0.000 claims description 159
• 238000003199 nucleic acid amplification method Methods 0.000 claims description 112
• 230000003321 amplification Effects 0.000 claims description 111
• 238000006243 chemical reaction Methods 0.000 claims description 102
• 239000002299 complementary DNA Substances 0.000 claims description 97
• 241000700605 Viruses Species 0.000 claims description 76
• 239000013598 vector Substances 0.000 claims description 74
• 238000009396 hybridization Methods 0.000 claims description 52
• 239000000203 mixture Substances 0.000 claims description 49
• 238000012216 screening Methods 0.000 claims description 46
• 150000001413 amino acids Chemical group 0.000 claims description 44
• 230000000295 complement effect Effects 0.000 claims description 43
• 239000002773 nucleotide Substances 0.000 claims description 36
• 125000003729 nucleotide group Chemical group 0.000 claims description 36
• 241000710781 Flaviviridae Species 0.000 claims description 35
• 241000709721 Hepatovirus A Species 0.000 claims description 21
• 230000004927 fusion Effects 0.000 claims description 19
• 230000027455 binding Effects 0.000 claims description 18
• 238000004519 manufacturing process Methods 0.000 claims description 17
• 241000724675 Hepatitis E virus Species 0.000 claims description 14
• 102000004190 Enzymes Human genes 0.000 claims description 13
• 108090000790 Enzymes Proteins 0.000 claims description 13
• 230000009385 viral infection Effects 0.000 claims description 10
• 208000037262 Hepatitis delta Diseases 0.000 claims description 9
• 241000724709 Hepatitis delta virus Species 0.000 claims description 9
• 241000288906 Primates Species 0.000 claims description 9
• 108010005774 beta-Galactosidase Proteins 0.000 claims description 9
• 241000700721 Hepatitis B virus Species 0.000 claims description 8
• 102100026189 Beta-galactosidase Human genes 0.000 claims description 7
• 108010070675 Glutathione transferase Proteins 0.000 claims description 4
• 102000005720 Glutathione transferase Human genes 0.000 claims description 4
• 238000012258 culturing Methods 0.000 claims description 4
• 108020004511 Recombinant DNA Proteins 0.000 claims description 3
• 239000013599 cloning vector Substances 0.000 claims description 3
• 230000036046 immunoreaction Effects 0.000 claims description 3
• 239000005547 deoxyribonucleotide Substances 0.000 claims description 2
• 125000002637 deoxyribonucleotide group Chemical group 0.000 claims description 2
• 210000001124 body fluid Anatomy 0.000 claims 5
• 239000010839 body fluid Substances 0.000 claims 5
• 230000001900 immune effect Effects 0.000 claims 2
• 238000007899 nucleic acid hybridization Methods 0.000 claims 1
• 238000002360 preparation method Methods 0.000 abstract description 19
• 230000000890 antigenic effect Effects 0.000 abstract description 15
• 238000002955 isolation Methods 0.000 abstract description 15
• 238000002405 diagnostic procedure Methods 0.000 abstract description 3
• 108020004414 DNA Proteins 0.000 description 158
• 235000018102 proteins Nutrition 0.000 description 141
• 238000003752 polymerase chain reaction Methods 0.000 description 130
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 129
• 241000711549 Hepacivirus C Species 0.000 description 73
• 239000000047 product Substances 0.000 description 71
• 210000004027 cell Anatomy 0.000 description 70
• 230000003612 virological effect Effects 0.000 description 67
• 108020001507 fusion proteins Proteins 0.000 description 58
• 102000037865 fusion proteins Human genes 0.000 description 55
• 241000282414 Homo sapiens Species 0.000 description 54
• 125000003275 alpha amino acid group Chemical group 0.000 description 43
• 238000003556 assay Methods 0.000 description 41
• 208000015181 infectious disease Diseases 0.000 description 41
• 239000000499 gel Substances 0.000 description 38
• 238000001262 western blot Methods 0.000 description 38
• 210000004369 blood Anatomy 0.000 description 37
• 239000008280 blood Substances 0.000 description 37
• 239000000872 buffer Substances 0.000 description 37
• 239000002245 particle Substances 0.000 description 36
• 235000001014 amino acid Nutrition 0.000 description 34
• 238000004458 analytical method Methods 0.000 description 32
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 31
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
• 108091034117 Oligonucleotide Proteins 0.000 description 28
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 26
• 239000000243 solution Substances 0.000 description 26
• 108091026890 Coding region Proteins 0.000 description 25
• 238000010367 cloning Methods 0.000 description 25
• 239000006166 lysate Substances 0.000 description 25
• 241000588724 Escherichia coli Species 0.000 description 22
• 241001465754 Metazoa Species 0.000 description 22
• 101710144111 Non-structural protein 3 Proteins 0.000 description 22
• 230000029087 digestion Effects 0.000 description 21
• 230000009257 reactivity Effects 0.000 description 21
• 238000012408 PCR amplification Methods 0.000 description 20
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 20
• 210000004185 liver Anatomy 0.000 description 20
• 239000000463 material Substances 0.000 description 20
• 239000002953 phosphate buffered saline Substances 0.000 description 20
• 239000013612 plasmid Substances 0.000 description 20
• BPHPUYQFMNQIOC-MBOVONDJSA-N (2r,3r,4s,5r)-2-(hydroxymethyl)-6-propan-2-ylsulfanyloxane-3,4,5-triol Chemical compound CC(C)SC1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-MBOVONDJSA-N 0.000 description 19
• 230000015572 biosynthetic process Effects 0.000 description 19
• 239000003153 chemical reaction reagent Substances 0.000 description 19
• 238000000746 purification Methods 0.000 description 19
• 239000007983 Tris buffer Substances 0.000 description 18
• 230000010076 replication Effects 0.000 description 18
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 18
• 241000283973 Oryctolagus cuniculus Species 0.000 description 17
• 239000000758 substrate Substances 0.000 description 17
• 239000003795 chemical substances by application Substances 0.000 description 16
• 230000002163 immunogen Effects 0.000 description 16
• 239000012528 membrane Substances 0.000 description 16
• 239000011780 sodium chloride Substances 0.000 description 16
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
• 210000001519 tissue Anatomy 0.000 description 15
• 108020004635 Complementary DNA Proteins 0.000 description 14
• 102100034349 Integrase Human genes 0.000 description 14
• 239000000020 Nitrocellulose Substances 0.000 description 14
• 101710144121 Non-structural protein 5 Proteins 0.000 description 14
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 14
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 14
• 238000001962 electrophoresis Methods 0.000 description 14
• 239000013604 expression vector Substances 0.000 description 14
• 235000014304 histidine Nutrition 0.000 description 14
• 229920001220 nitrocellulos Polymers 0.000 description 14
• 239000008188 pellet Substances 0.000 description 14
• 238000003757 reverse transcription PCR Methods 0.000 description 14
• 241000701447 unidentified baculovirus Species 0.000 description 14
• 108010024636 Glutathione Proteins 0.000 description 13
• 238000004113 cell culture Methods 0.000 description 13
• 229960003180 glutathione Drugs 0.000 description 13
• 230000004048 modification Effects 0.000 description 13
• 238000012986 modification Methods 0.000 description 13
• 241000894007 species Species 0.000 description 13
• 238000003786 synthesis reaction Methods 0.000 description 13
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 12
• 238000013459 approach Methods 0.000 description 12
• 230000008901 benefit Effects 0.000 description 12
• 201000010099 disease Diseases 0.000 description 12
• 229940088598 enzyme Drugs 0.000 description 12
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 12
• 238000007834 ligase chain reaction Methods 0.000 description 12
• 239000011541 reaction mixture Substances 0.000 description 12
• 238000010561 standard procedure Methods 0.000 description 12
• 108060004795 Methyltransferase Proteins 0.000 description 11
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 11
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 11
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 11
• 238000001042 affinity chromatography Methods 0.000 description 11
• 239000011324 bead Substances 0.000 description 11
• 238000005119 centrifugation Methods 0.000 description 11
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 11
• 238000002474 experimental method Methods 0.000 description 11
• 238000003018 immunoassay Methods 0.000 description 11
• 238000000338 in vitro Methods 0.000 description 11
• 238000011534 incubation Methods 0.000 description 11
• 238000010839 reverse transcription Methods 0.000 description 11
• 208000005176 Hepatitis C Diseases 0.000 description 10
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 10
• 108010067390 Viral Proteins Proteins 0.000 description 10
• 239000002253 acid Substances 0.000 description 10
• 238000010804 cDNA synthesis Methods 0.000 description 10
• 150000001875 compounds Chemical class 0.000 description 10
• 238000009472 formulation Methods 0.000 description 10
• 238000001502 gel electrophoresis Methods 0.000 description 10
• 241000894006 Bacteria Species 0.000 description 9
• 241000283707 Capra Species 0.000 description 9
• 101710118188 DNA-binding protein HU-alpha Proteins 0.000 description 9
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
• 101710144128 Non-structural protein 2 Proteins 0.000 description 9
• 101710199667 Nuclear export protein Proteins 0.000 description 9
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 9
• 238000010171 animal model Methods 0.000 description 9
• 230000002238 attenuated effect Effects 0.000 description 9
• 230000001413 cellular effect Effects 0.000 description 9
• 238000012512 characterization method Methods 0.000 description 9
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
• -1 nucleic acid acids Chemical class 0.000 description 9
• 239000002751 oligonucleotide probe Substances 0.000 description 9
• 229920002401 polyacrylamide Polymers 0.000 description 9
• 230000001681 protective effect Effects 0.000 description 9
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 9
• 238000012546 transfer Methods 0.000 description 9
• 230000014616 translation Effects 0.000 description 9
• 238000011282 treatment Methods 0.000 description 9
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 8
• 206010008909 Chronic Hepatitis Diseases 0.000 description 8
• 238000001712 DNA sequencing Methods 0.000 description 8
• 238000002965 ELISA Methods 0.000 description 8
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
• 108091028043 Nucleic acid sequence Proteins 0.000 description 8
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 8
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
• 230000002788 anti-peptide Effects 0.000 description 8
• 230000001580 bacterial effect Effects 0.000 description 8
• 238000003776 cleavage reaction Methods 0.000 description 8
• 238000011161 development Methods 0.000 description 8
• 238000010790 dilution Methods 0.000 description 8
• 239000012895 dilution Substances 0.000 description 8
• 210000003494 hepatocyte Anatomy 0.000 description 8
• 238000001727 in vivo Methods 0.000 description 8
• 208000019423 liver disease Diseases 0.000 description 8
• 239000013642 negative control Substances 0.000 description 8
• 239000013641 positive control Substances 0.000 description 8
• 230000002441 reversible effect Effects 0.000 description 8
• 230000007017 scission Effects 0.000 description 8
• 238000005406 washing Methods 0.000 description 8
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 7
• 108091035707 Consensus sequence Proteins 0.000 description 7
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 7
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 7
• 108010010803 Gelatin Proteins 0.000 description 7
• 241000238631 Hexapoda Species 0.000 description 7
• 101710172711 Structural protein Proteins 0.000 description 7
• 229930006000 Sucrose Natural products 0.000 description 7
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
• 239000004202 carbamide Substances 0.000 description 7
• 238000004587 chromatography analysis Methods 0.000 description 7
• 230000000694 effects Effects 0.000 description 7
• 238000005516 engineering process Methods 0.000 description 7
• 239000008273 gelatin Substances 0.000 description 7
• 229920000159 gelatin Polymers 0.000 description 7
• 235000019322 gelatine Nutrition 0.000 description 7
• 235000011852 gelatine desserts Nutrition 0.000 description 7
• 238000011081 inoculation Methods 0.000 description 7
• 210000004698 lymphocyte Anatomy 0.000 description 7
• 229940126619 mouse monoclonal antibody Drugs 0.000 description 7
• 230000002829 reductive effect Effects 0.000 description 7
• 230000035945 sensitivity Effects 0.000 description 7
• 239000000126 substance Substances 0.000 description 7
• 239000005720 sucrose Substances 0.000 description 7
• 238000013519 translation Methods 0.000 description 7
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
• 241000282693 Cercopithecidae Species 0.000 description 6
• 102000012410 DNA Ligases Human genes 0.000 description 6
• 108010061982 DNA Ligases Proteins 0.000 description 6
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 6
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 6
• 241000710831 Flavivirus Species 0.000 description 6
• 241000282412 Homo Species 0.000 description 6
• 102000014150 Interferons Human genes 0.000 description 6
• 108010050904 Interferons Proteins 0.000 description 6
• 238000010222 PCR analysis Methods 0.000 description 6
• 229920001213 Polysorbate 20 Polymers 0.000 description 6
• 108010076504 Protein Sorting Signals Proteins 0.000 description 6
• 208000036142 Viral infection Diseases 0.000 description 6
• 239000011543 agarose gel Substances 0.000 description 6
• 229940098773 bovine serum albumin Drugs 0.000 description 6
• 210000004899 c-terminal region Anatomy 0.000 description 6
• 238000010276 construction Methods 0.000 description 6
• 230000001419 dependent effect Effects 0.000 description 6
• 230000006870 function Effects 0.000 description 6
• 238000003780 insertion Methods 0.000 description 6
• 230000037431 insertion Effects 0.000 description 6
• YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 6
• 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 6
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 6
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 6
• 108091008146 restriction endonucleases Proteins 0.000 description 6
• 239000007787 solid Substances 0.000 description 6
• 239000007790 solid phase Substances 0.000 description 6
• 230000001225 therapeutic effect Effects 0.000 description 6
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
• 229920000936 Agarose Polymers 0.000 description 5
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
• 102000053602 DNA Human genes 0.000 description 5
• 101150093545 EXPA3 gene Proteins 0.000 description 5
• 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 5
• 101710203526 Integrase Proteins 0.000 description 5
• 241000282567 Macaca fascicularis Species 0.000 description 5
• 241000282579 Pan Species 0.000 description 5
• 239000002202 Polyethylene glycol Substances 0.000 description 5
• 108010076039 Polyproteins Proteins 0.000 description 5
• 239000013614 RNA sample Substances 0.000 description 5
• IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 5
• 108020000999 Viral RNA Proteins 0.000 description 5
• 230000001154 acute effect Effects 0.000 description 5
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
• 229960000723 ampicillin Drugs 0.000 description 5
• 238000012790 confirmation Methods 0.000 description 5
• 238000004925 denaturation Methods 0.000 description 5
• 230000036425 denaturation Effects 0.000 description 5
• 239000003814 drug Substances 0.000 description 5
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 5
• 229960005542 ethidium bromide Drugs 0.000 description 5
• 230000028993 immune response Effects 0.000 description 5
• 239000003112 inhibitor Substances 0.000 description 5
• 238000004255 ion exchange chromatography Methods 0.000 description 5
• 239000011159 matrix material Substances 0.000 description 5
• 239000002609 medium Substances 0.000 description 5
• 229910021645 metal ion Inorganic materials 0.000 description 5
• 101150109310 msrAB1 gene Proteins 0.000 description 5
• 229920001223 polyethylene glycol Polymers 0.000 description 5
• 229920000642 polymer Polymers 0.000 description 5
• 238000001556 precipitation Methods 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 5
• 229960000329 ribavirin Drugs 0.000 description 5
• 238000012163 sequencing technique Methods 0.000 description 5
• 238000010186 staining Methods 0.000 description 5
• 239000006228 supernatant Substances 0.000 description 5
• 238000013518 transcription Methods 0.000 description 5
• 230000035897 transcription Effects 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 4
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 4
• 108020004705 Codon Proteins 0.000 description 4
• 206010019791 Hepatitis post transfusion Diseases 0.000 description 4
• 206010019799 Hepatitis viral Diseases 0.000 description 4
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 4
• 108091005804 Peptidases Proteins 0.000 description 4
• 108091034057 RNA (poly(A)) Proteins 0.000 description 4
• 108010006785 Taq Polymerase Proteins 0.000 description 4
• 239000002671 adjuvant Substances 0.000 description 4
• 238000001261 affinity purification Methods 0.000 description 4
• 230000000840 anti-viral effect Effects 0.000 description 4
• 239000000074 antisense oligonucleotide Substances 0.000 description 4
• 238000012230 antisense oligonucleotides Methods 0.000 description 4
• 239000003443 antiviral agent Substances 0.000 description 4
• 230000005540 biological transmission Effects 0.000 description 4
• 230000001684 chronic effect Effects 0.000 description 4
• SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 4
• SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 4
• RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 4
• HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 4
• 239000003599 detergent Substances 0.000 description 4
• 239000012153 distilled water Substances 0.000 description 4
• 229940079593 drug Drugs 0.000 description 4
• 239000000284 extract Substances 0.000 description 4
• 238000000605 extraction Methods 0.000 description 4
• 230000002068 genetic effect Effects 0.000 description 4
• 239000011521 glass Substances 0.000 description 4
• ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 4
• 208000002672 hepatitis B Diseases 0.000 description 4
• 125000000487 histidyl group Chemical class [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 4
• 230000003053 immunization Effects 0.000 description 4
• 238000002649 immunization Methods 0.000 description 4
• 230000003993 interaction Effects 0.000 description 4
• 210000003292 kidney cell Anatomy 0.000 description 4
• 239000002502 liposome Substances 0.000 description 4
• KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
• 229910001629 magnesium chloride Inorganic materials 0.000 description 4
• 210000004962 mammalian cell Anatomy 0.000 description 4
• 229930182817 methionine Natural products 0.000 description 4
• 230000005012 migration Effects 0.000 description 4
• 238000013508 migration Methods 0.000 description 4
• 230000003278 mimic effect Effects 0.000 description 4
• 239000003960 organic solvent Substances 0.000 description 4
• 238000003259 recombinant expression Methods 0.000 description 4
• 230000032258 transport Effects 0.000 description 4
• 238000002255 vaccination Methods 0.000 description 4
• 230000029812 viral genome replication Effects 0.000 description 4
• 201000001862 viral hepatitis Diseases 0.000 description 4
• 210000002845 virion Anatomy 0.000 description 4
• QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 3
• 208000030507 AIDS Diseases 0.000 description 3
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 208000003322 Coinfection Diseases 0.000 description 3
• 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 3
• 108010053770 Deoxyribonucleases Proteins 0.000 description 3
• 102000016911 Deoxyribonucleases Human genes 0.000 description 3
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
• 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 3
• 208000032843 Hemorrhage Diseases 0.000 description 3
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 3
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
• 102000003960 Ligases Human genes 0.000 description 3
• 108090000364 Ligases Proteins 0.000 description 3
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
• 239000004793 Polystyrene Substances 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• 108010090804 Streptavidin Proteins 0.000 description 3
• 108091036066 Three prime untranslated region Proteins 0.000 description 3
• 108091023045 Untranslated Region Proteins 0.000 description 3
• 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 3
• 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 3
• 206010058874 Viraemia Diseases 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 231100000354 acute hepatitis Toxicity 0.000 description 3
• 238000000246 agarose gel electrophoresis Methods 0.000 description 3
• 238000000137 annealing Methods 0.000 description 3
• 238000000376 autoradiography Methods 0.000 description 3
• 238000007675 cardiac surgery Methods 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 230000015556 catabolic process Effects 0.000 description 3
• 239000013592 cell lysate Substances 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 239000000356 contaminant Substances 0.000 description 3
• 238000007796 conventional method Methods 0.000 description 3
• 238000001816 cooling Methods 0.000 description 3
• 238000006731 degradation reaction Methods 0.000 description 3
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 3
• 210000004408 hybridoma Anatomy 0.000 description 3
• 230000001965 increasing effect Effects 0.000 description 3
• 230000006698 induction Effects 0.000 description 3
• 239000012678 infectious agent Substances 0.000 description 3
• 230000002458 infectious effect Effects 0.000 description 3
• 229940047124 interferons Drugs 0.000 description 3
• 238000002372 labelling Methods 0.000 description 3
• 229910052751 metal Inorganic materials 0.000 description 3
• 239000002184 metal Substances 0.000 description 3
• 150000002739 metals Chemical class 0.000 description 3
• 230000035772 mutation Effects 0.000 description 3
• 238000010647 peptide synthesis reaction Methods 0.000 description 3
• 239000000546 pharmaceutical excipient Substances 0.000 description 3
• 229920002223 polystyrene Polymers 0.000 description 3
• 230000003389 potentiating effect Effects 0.000 description 3
• 230000002265 prevention Effects 0.000 description 3
• 235000019419 proteases Nutrition 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 238000004062 sedimentation Methods 0.000 description 3
• 238000000926 separation method Methods 0.000 description 3
• 238000003860 storage Methods 0.000 description 3
• 208000024891 symptom Diseases 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 238000012800 visualization Methods 0.000 description 3
• NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
• OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 2
• HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
• 229920001817 Agar Polymers 0.000 description 2
• 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
• 241000710777 Classical swine fever virus Species 0.000 description 2
• 230000004544 DNA amplification Effects 0.000 description 2
• 239000003298 DNA probe Substances 0.000 description 2
• AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 2
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
• 206010059866 Drug resistance Diseases 0.000 description 2
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
• 206010019755 Hepatitis chronic active Diseases 0.000 description 2
• 206010019759 Hepatitis chronic persistent Diseases 0.000 description 2
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
• 101710125507 Integrase/recombinase Proteins 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 239000006142 Luria-Bertani Agar Substances 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 238000000636 Northern blotting Methods 0.000 description 2
• 101710163270 Nuclease Proteins 0.000 description 2
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
• 239000004677 Nylon Substances 0.000 description 2
• 108700020796 Oncogene Proteins 0.000 description 2
• 102000043276 Oncogene Human genes 0.000 description 2
• 238000002944 PCR assay Methods 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 241000282577 Pan troglodytes Species 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 208000037581 Persistent Infection Diseases 0.000 description 2
• 206010037660 Pyrexia Diseases 0.000 description 2
• 238000010240 RT-PCR analysis Methods 0.000 description 2
• 241000220010 Rhode Species 0.000 description 2
• 102000006382 Ribonucleases Human genes 0.000 description 2
• 108010083644 Ribonucleases Proteins 0.000 description 2
• 102100030852 Run domain Beclin-1-interacting and cysteine-rich domain-containing protein Human genes 0.000 description 2
• 239000012722 SDS sample buffer Substances 0.000 description 2
• 108010022999 Serine Proteases Proteins 0.000 description 2
• 102000012479 Serine Proteases Human genes 0.000 description 2
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
• 238000002105 Southern blotting Methods 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 206010046865 Vaccinia virus infection Diseases 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 238000002835 absorbance Methods 0.000 description 2
• 238000010521 absorption reaction Methods 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 239000008272 agar Substances 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
• 208000007502 anemia Diseases 0.000 description 2
• 238000005349 anion exchange Methods 0.000 description 2
• OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 208000034158 bleeding Diseases 0.000 description 2
• 230000000740 bleeding effect Effects 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 239000006143 cell culture medium Substances 0.000 description 2
• 230000003915 cell function Effects 0.000 description 2
• 230000007969 cellular immunity Effects 0.000 description 2
• 239000002738 chelating agent Substances 0.000 description 2
• 239000007795 chemical reaction product Substances 0.000 description 2
• NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
• 201000003740 cowpox Diseases 0.000 description 2
• 125000004122 cyclic group Chemical group 0.000 description 2
• 230000009089 cytolysis Effects 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 238000009792 diffusion process Methods 0.000 description 2
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 239000003937 drug carrier Substances 0.000 description 2
• 230000009977 dual effect Effects 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 210000002308 embryonic cell Anatomy 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 238000012869 ethanol precipitation Methods 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 238000005194 fractionation Methods 0.000 description 2
• 108010074605 gamma-Globulins Proteins 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• 239000001963 growth medium Substances 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• 208000010710 hepatitis C virus infection Diseases 0.000 description 2
• 201000010284 hepatitis E Diseases 0.000 description 2
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 239000001257 hydrogen Substances 0.000 description 2
• 210000001144 hymen Anatomy 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 238000010185 immunofluorescence analysis Methods 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 239000002054 inoculum Substances 0.000 description 2
• 229940079322 interferon Drugs 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
• 239000003446 ligand Substances 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 238000012317 liver biopsy Methods 0.000 description 2
• 230000003908 liver function Effects 0.000 description 2
• 238000011068 loading method Methods 0.000 description 2
• 239000012139 lysis buffer Substances 0.000 description 2
• 229920002521 macromolecule Polymers 0.000 description 2
• 230000014759 maintenance of location Effects 0.000 description 2
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
• 230000037230 mobility Effects 0.000 description 2
• 239000002808 molecular sieve Substances 0.000 description 2
• 239000002853 nucleic acid probe Substances 0.000 description 2
• 229920001778 nylon Polymers 0.000 description 2
• 230000008520 organization Effects 0.000 description 2
• 230000005298 paramagnetic effect Effects 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 244000052769 pathogen Species 0.000 description 2
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
• 239000012071 phase Substances 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 2
• 238000012809 post-inoculation Methods 0.000 description 2
• 230000003449 preventive effect Effects 0.000 description 2
• 238000001742 protein purification Methods 0.000 description 2
• 230000006337 proteolytic cleavage Effects 0.000 description 2
• ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
• 239000012264 purified product Substances 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 239000011347 resin Substances 0.000 description 2
• 229920005989 resin Polymers 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• 230000001177 retroviral effect Effects 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
• 230000000405 serological effect Effects 0.000 description 2
• URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
• 239000001488 sodium phosphate Substances 0.000 description 2
• 229910000162 sodium phosphate Inorganic materials 0.000 description 2
• 235000011008 sodium phosphates Nutrition 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 150000008163 sugars Chemical class 0.000 description 2
• 239000000829 suppository Substances 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 230000002459 sustained effect Effects 0.000 description 2
• 230000007704 transition Effects 0.000 description 2
• 230000014621 translational initiation Effects 0.000 description 2
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
• 238000005199 ultracentrifugation Methods 0.000 description 2
• 208000007089 vaccinia Diseases 0.000 description 2
• 239000012130 whole-cell lysate Substances 0.000 description 2
• GJLXVWOMRRWCIB-MERZOTPQSA-N (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanamide Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=C(O)C=C1 GJLXVWOMRRWCIB-MERZOTPQSA-N 0.000 description 1
• QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
• LVRFTAZAXQPQHI-RXMQYKEDSA-N (R)-2-hydroxy-4-methylpentanoic acid Chemical group CC(C)C[C@@H](O)C(O)=O LVRFTAZAXQPQHI-RXMQYKEDSA-N 0.000 description 1
• GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
• LOLNFJHUEIDGNH-PIXDULNESA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(e)-2-iodoethenyl]pyrimidine-2,4-dione Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(\C=C\I)=C1 LOLNFJHUEIDGNH-PIXDULNESA-N 0.000 description 1
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• 101150110188 30 gene Proteins 0.000 description 1
• VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
• 241000238876 Acari Species 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• JQDFGZKKXBEANU-IMJSIDKUSA-N Ala-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](CS)C(O)=O JQDFGZKKXBEANU-IMJSIDKUSA-N 0.000 description 1
• 101710096214 Alanine aminotransferase 1 Proteins 0.000 description 1
• 108010082126 Alanine transaminase Proteins 0.000 description 1
• 244000153158 Ammi visnaga Species 0.000 description 1
• 235000010585 Ammi visnaga Nutrition 0.000 description 1
• 241000272525 Anas platyrhynchos Species 0.000 description 1
• 206010002942 Apathy Diseases 0.000 description 1
• 108010039627 Aprotinin Proteins 0.000 description 1
• 101100296980 Arabidopsis thaliana PEP6 gene Proteins 0.000 description 1
• 241000238421 Arthropoda Species 0.000 description 1
• 206010003827 Autoimmune hepatitis Diseases 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 108020000946 Bacterial DNA Proteins 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 101710155617 Beta-galactosidase 10 Proteins 0.000 description 1
• 108010055991 BglII endonuclease Proteins 0.000 description 1
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
• 208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 241000255789 Bombyx mori Species 0.000 description 1
• ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 101150050163 CERT1 gene Proteins 0.000 description 1
• 101100176801 Caenorhabditis elegans gst-10 gene Proteins 0.000 description 1
• 101100189913 Caenorhabditis elegans pept-1 gene Proteins 0.000 description 1
• 101100065878 Caenorhabditis elegans sec-10 gene Proteins 0.000 description 1
• 101100273249 Candida albicans (strain SC5314 / ATCC MYA-2876) SAP1 gene Proteins 0.000 description 1
• 108090000565 Capsid Proteins Proteins 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 201000006082 Chickenpox Diseases 0.000 description 1
• 108010077544 Chromatin Proteins 0.000 description 1
• 208000017667 Chronic Disease Diseases 0.000 description 1
• 241000543381 Cliftonia monophylla Species 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 102100031673 Corneodesmosin Human genes 0.000 description 1
• 101710139375 Corneodesmosin Proteins 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
• 241000195493 Cryptophyta Species 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
• 102000004594 DNA Polymerase I Human genes 0.000 description 1
• 108010017826 DNA Polymerase I Proteins 0.000 description 1
• 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
• 230000003682 DNA packaging effect Effects 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 241000255925 Diptera Species 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 108010067770 Endopeptidase K Proteins 0.000 description 1
• 241001288713 Escherichia coli MC1061 Species 0.000 description 1
• 241000701959 Escherichia virus Lambda Species 0.000 description 1
• QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
• 208000010201 Exanthema Diseases 0.000 description 1
• 206010016654 Fibrosis Diseases 0.000 description 1
• 208000004576 Flaviviridae Infections Diseases 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 229920002527 Glycogen Polymers 0.000 description 1
• 108060003393 Granulin Proteins 0.000 description 1
• 108010010369 HIV Protease Proteins 0.000 description 1
• 208000005331 Hepatitis D Diseases 0.000 description 1
• 101000856199 Homo sapiens Chymotrypsin-like protease CTRL-1 Proteins 0.000 description 1
• 101000743353 Homo sapiens Vacuolar protein sorting-associated protein 11 homolog Proteins 0.000 description 1
• 101000782453 Homo sapiens Vacuolar protein sorting-associated protein 18 homolog Proteins 0.000 description 1
• 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 229930010555 Inosine Natural products 0.000 description 1
• UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• 241000282560 Macaca mulatta Species 0.000 description 1
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 101100243377 Mus musculus Pepd gene Proteins 0.000 description 1
• 241001460678 Napo <wasp> Species 0.000 description 1
• 101800001020 Non-structural protein 4A Proteins 0.000 description 1
• 101800001019 Non-structural protein 4B Proteins 0.000 description 1
• 101800001014 Non-structural protein 5A Proteins 0.000 description 1
• 108091092724 Noncoding DNA Proteins 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 239000012807 PCR reagent Substances 0.000 description 1
• 101150029183 PEP4 gene Proteins 0.000 description 1
• 241000609499 Palicourea Species 0.000 description 1
• 241000282520 Papio Species 0.000 description 1
• 108010088535 Pep-1 peptide Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 241000710778 Pestivirus Species 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 101710182846 Polyhedrin Proteins 0.000 description 1
• 102000015623 Polynucleotide Adenylyltransferase Human genes 0.000 description 1
• 108010024055 Polynucleotide adenylyltransferase Proteins 0.000 description 1
• SBQAKZYUNWNIRL-WIPKXTQKSA-N Prednisolone farnesylate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)/C=C(C)/CC/C=C(C)/CCC=C(C)C)(O)[C@@]1(C)C[C@@H]2O SBQAKZYUNWNIRL-WIPKXTQKSA-N 0.000 description 1
• 208000012654 Primary biliary cholangitis Diseases 0.000 description 1
• 101710192141 Protein Nef Proteins 0.000 description 1
• 241000287531 Psittacidae Species 0.000 description 1
• 108090000944 RNA Helicases Proteins 0.000 description 1
• 102000004409 RNA Helicases Human genes 0.000 description 1
• 238000002123 RNA extraction Methods 0.000 description 1
• 101710086015 RNA ligase Proteins 0.000 description 1
• 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 1
• 206010037742 Rabies Diseases 0.000 description 1
• 241000220317 Rosa Species 0.000 description 1
• KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
• 101100189862 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PEP8 gene Proteins 0.000 description 1
• 101100428743 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) VPS5 gene Proteins 0.000 description 1
• 101100428706 Schizosaccharomyces pombe (strain 972 / ATCC 24843) vps26 gene Proteins 0.000 description 1
• 206010070834 Sensitisation Diseases 0.000 description 1
• 229920005654 Sephadex Polymers 0.000 description 1
• 238000010266 Sephadex chromatography Methods 0.000 description 1
• 239000012507 Sephadex™ Substances 0.000 description 1
• 229920002684 Sepharose Polymers 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• 241000256251 Spodoptera frugiperda Species 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 108700005078 Synthetic Genes Proteins 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 206010043395 Thalassaemia sickle cell Diseases 0.000 description 1
• 244000269722 Thea sinensis Species 0.000 description 1
• 241000589500 Thermus aquaticus Species 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 102100038309 Vacuolar protein sorting-associated protein 11 homolog Human genes 0.000 description 1
• 102100035870 Vacuolar protein sorting-associated protein 18 homolog Human genes 0.000 description 1
• 206010046980 Varicella Diseases 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
• 241000710772 Yellow fever virus Species 0.000 description 1
• HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 230000004913 activation Effects 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 230000006978 adaptation Effects 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 238000003314 affinity selection Methods 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 125000003172 aldehyde group Chemical group 0.000 description 1
• 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
• 239000002168 alkylating agent Substances 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 210000003423 ankle Anatomy 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 230000002155 anti-virotic effect Effects 0.000 description 1
• 229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 description 1
• 229960004405 aprotinin Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 230000001588 bifunctional effect Effects 0.000 description 1
• 210000000941 bile Anatomy 0.000 description 1
• 239000012472 biological sample Substances 0.000 description 1
• 229920001222 biopolymer Polymers 0.000 description 1
• 239000010836 blood and blood product Substances 0.000 description 1
• 229940125691 blood product Drugs 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 238000009835 boiling Methods 0.000 description 1
• 229910052796 boron Inorganic materials 0.000 description 1
• UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
• 238000010805 cDNA synthesis kit Methods 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
• YDMCWONVABEGBK-UHFFFAOYSA-N carbamimidoylazanium;phenoxide Chemical compound NC(N)=N.OC1=CC=CC=C1 YDMCWONVABEGBK-UHFFFAOYSA-N 0.000 description 1
• 239000011545 carbonate/bicarbonate buffer Substances 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 239000012677 causal agent Substances 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 108091092356 cellular DNA Proteins 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 235000010980 cellulose Nutrition 0.000 description 1
• 239000013522 chelant Substances 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• BKHZIBWEHPHYAI-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol Chemical compound ClC(Cl)Cl.CC(C)CCO BKHZIBWEHPHYAI-UHFFFAOYSA-N 0.000 description 1
• YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
• 210000003483 chromatin Anatomy 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 230000007882 cirrhosis Effects 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• 239000007979 citrate buffer Substances 0.000 description 1
• 238000004140 cleaning Methods 0.000 description 1
• 238000012411 cloning technique Methods 0.000 description 1
• 238000012761 co-transfection Methods 0.000 description 1
• GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 230000009918 complex formation Effects 0.000 description 1
• 238000003271 compound fluorescence assay Methods 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 238000002809 confirmatory assay Methods 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 239000007822 coupling agent Substances 0.000 description 1
• 230000009260 cross reactivity Effects 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 239000000032 diagnostic agent Substances 0.000 description 1
• 229940039227 diagnostic agent Drugs 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 238000001085 differential centrifugation Methods 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 229940079919 digestives enzyme preparation Drugs 0.000 description 1
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
• 230000008034 disappearance Effects 0.000 description 1
• BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
• SDIXRDNYIMOKSG-UHFFFAOYSA-L disodium methyl arsenate Chemical compound [Na+].[Na+].C[As]([O-])([O-])=O SDIXRDNYIMOKSG-UHFFFAOYSA-L 0.000 description 1
• 229910000397 disodium phosphate Inorganic materials 0.000 description 1
• 235000019800 disodium phosphate Nutrition 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical group OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
• 235000020188 drinking water Nutrition 0.000 description 1
• 239000003651 drinking water Substances 0.000 description 1
• 229940000406 drug candidate Drugs 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 238000001493 electron microscopy Methods 0.000 description 1
• 239000012149 elution buffer Substances 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 230000009088 enzymatic function Effects 0.000 description 1
• 230000007247 enzymatic mechanism Effects 0.000 description 1
• 230000001973 epigenetic effect Effects 0.000 description 1
• 235000019439 ethyl acetate Nutrition 0.000 description 1
• DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
• 201000005884 exanthem Diseases 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 235000013861 fat-free Nutrition 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 238000012921 fluorescence analysis Methods 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 239000011888 foil Substances 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 210000002683 foot Anatomy 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 239000000054 fungal extract Substances 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 238000002523 gelfiltration Methods 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 229940096919 glycogen Drugs 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 229940029575 guanosine Drugs 0.000 description 1
• 150000003278 haem Chemical class 0.000 description 1
• 230000002008 hemorrhagic effect Effects 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 229960002520 hepatitis vaccine Drugs 0.000 description 1
• 230000003494 hepatotrophic effect Effects 0.000 description 1
• 101150107671 hisB gene Proteins 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 238000007849 hot-start PCR Methods 0.000 description 1
• 210000005104 human peripheral blood lymphocyte Anatomy 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 230000008105 immune reaction Effects 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 238000010820 immunofluorescence microscopy Methods 0.000 description 1
• 230000009851 immunogenic response Effects 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 230000004957 immunoregulator effect Effects 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000002401 inhibitory effect Effects 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229960003786 inosine Drugs 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 229960003130 interferon gamma Drugs 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
• 230000007794 irritation Effects 0.000 description 1
• SRCAXTIBNLIRHU-JJKPAIEPSA-N lantibiotic pep5 Chemical compound N([C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N\C(=C/C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N\C(=C/C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N\C(=C(/C)S)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)C(=O)CC SRCAXTIBNLIRHU-JJKPAIEPSA-N 0.000 description 1
• 239000004816 latex Substances 0.000 description 1
• 229920000126 latex Polymers 0.000 description 1
• 239000010410 layer Substances 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 229940124590 live attenuated vaccine Drugs 0.000 description 1
• 229940023012 live-attenuated vaccine Drugs 0.000 description 1
• 210000005229 liver cell Anatomy 0.000 description 1
• 230000005976 liver dysfunction Effects 0.000 description 1
• 239000003589 local anesthetic agent Substances 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 230000028744 lysogeny Effects 0.000 description 1
• 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
• HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 238000000386 microscopy Methods 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 235000015898 miriam Nutrition 0.000 description 1
• 230000002438 mitochondrial effect Effects 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• 229940031348 multivalent vaccine Drugs 0.000 description 1
• 210000000663 muscle cell Anatomy 0.000 description 1
• LCNBIHVSOPXFMR-UHFFFAOYSA-N n'-(3-aminopropyl)butane-1,4-diamine;hydron;trichloride Chemical compound Cl.Cl.Cl.NCCCCNCCCN LCNBIHVSOPXFMR-UHFFFAOYSA-N 0.000 description 1
• 229930014626 natural product Natural products 0.000 description 1
• 230000010807 negative regulation of binding Effects 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 230000002611 ovarian Effects 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 230000001590 oxidative effect Effects 0.000 description 1
• 239000006179 pH buffering agent Substances 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 238000012856 packing Methods 0.000 description 1
• 239000003973 paint Substances 0.000 description 1
• 239000013618 particulate matter Substances 0.000 description 1
• 238000005192 partition Methods 0.000 description 1
• 235000015927 pasta Nutrition 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 238000005453 pelletization Methods 0.000 description 1
• 101150096366 pep7 gene Proteins 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 102000013415 peroxidase activity proteins Human genes 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 230000002085 persistent effect Effects 0.000 description 1
• 238000002823 phage display Methods 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 230000010287 polarization Effects 0.000 description 1
• 229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 239000000843 powder Substances 0.000 description 1
• 238000012808 pre-inoculation Methods 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 238000002203 pretreatment Methods 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 230000004952 protein activity Effects 0.000 description 1
• 229940023143 protein vaccine Drugs 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 238000000763 radioactive isotope labeling Methods 0.000 description 1
• 206010037844 rash Diseases 0.000 description 1
• 239000012429 reaction media Substances 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 238000004153 renaturation Methods 0.000 description 1
• 238000009877 rendering Methods 0.000 description 1
• 125000006853 reporter group Chemical group 0.000 description 1
• 238000002271 resection Methods 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 238000007363 ring formation reaction Methods 0.000 description 1
• 229910052707 ruthenium Inorganic materials 0.000 description 1
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
• 229940081974 saccharin Drugs 0.000 description 1
• 235000019204 saccharin Nutrition 0.000 description 1
• 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 238000011896 sensitive detection Methods 0.000 description 1
• 230000008313 sensitization Effects 0.000 description 1
• 239000012679 serum free medium Substances 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 208000007056 sickle cell anemia Diseases 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 239000002356 single layer Substances 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 210000002027 skeletal muscle Anatomy 0.000 description 1
• 235000020183 skimmed milk Nutrition 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 108010076805 snowdrop lectin Proteins 0.000 description 1
• 235000017557 sodium bicarbonate Nutrition 0.000 description 1
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
• 238000005063 solubilization Methods 0.000 description 1
• 230000007928 solubilization Effects 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 239000012089 stop solution Substances 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 125000003831 tetrazolyl group Chemical group 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
• 108010087967 type I signal peptidase Proteins 0.000 description 1
• 238000000108 ultra-filtration Methods 0.000 description 1
• 241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 210000000689 upper leg Anatomy 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 238000012795 verification Methods 0.000 description 1
• 229920002554 vinyl polymer Polymers 0.000 description 1
• 230000009447 viral pathogenesis Effects 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 229940051021 yellow-fever virus Drugs 0.000 description 1